Evidence map›Paper›PMID 33679421›Full record

ArticleFrontiers in pharmacology2021

Luteolin Alleviates Methamphetamine-Induced Hepatotoxicity by Suppressing the p53 Pathway-Mediated Apoptosis, Autophagy, and Inflammation in Rats.

Kai-Kai Zhang, Hui Wang, Dong Qu, Li-Jian Chen, Li-Bin Wang, Jia-Hao Li, Jia-Li Liu, Ling-Ling Xu, Jamie Still Yoshida, Jing-Tao Xu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Flavonoid Rich Black Currant (Molecules (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. Silencing theInternational journal of molecular sciences · 2022
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Kai-Kai ZhangDepartment of Forensic Pathology, School of Forensic Medicine, Southern Medical University, Guangzhou, China.
Hui WangDepartment of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Dong QuDepartment of Forensic Pathology, School of Forensic Medicine, Southern Medical University, Guangzhou, China.
Li-Jian ChenDepartment of Forensic Pathology, School of Forensic Medicine, Southern Medical University, Guangzhou, China.
Li-Bin WangDepartment of Toxicology, School of Public Health, Southern Medical University, Guangzhou, China.
Jia-Hao LiDepartment of Forensic Pathology, School of Forensic Medicine, Southern Medical University, Guangzhou, China.
Jia-Li LiuDepartment of Forensic Pathology, School of Forensic Medicine, Southern Medical University, Guangzhou, China.
Ling-Ling XuDepartment of Toxicology, School of Public Health, Southern Medical University, Guangzhou, China.
Jamie Still YoshidaFaculty of Health Sciences, Butsuryo College of Osaka, Sakai, Japan.
Jing-Tao XuShanghai Key Laboratory of Forensic Medicine, Institute of Forensic Science, Ministry of Justice, Shanghai, China.
Xiao-Li XieDepartment of Toxicology, School of Public Health, Southern Medical University, Guangzhou, China.
Dong-Ri LiDepartment of Forensic Evidence Science, School of Forensic Medicine, Southern Medical University, Guangzhou, China.
Southern Medical University · CNGuangzhou Medical University · CNInstitute of Forensic Science · CNOsaka Butsuryo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Misuse of the psychostimulant methamphetamine (METH) could induce serious hepatotoxicity. Our previous study revealed the effects of luteolin on alleviating METH-induced hepatotoxicity, however, the detailed mechanisms have not been elucidated. In this study, rats were orally pretreated with 100 mg/kg luteolin or sodium dodecyl sulfate water, and then METH (15 mg/kg, intraperitoneal [i.p.]) or saline was administered. Histopathological and biochemical analyses were used to determine the alleviative effects of luteolin. Based on the RNA-sequencing data, METH induced 1859 differentially expressed genes (DEGs) in comparison with the control group, which were enriched into 11 signaling pathways. Among these DEGs, 497 DEGs could be regulated through luteolin treatment and enriched into 16 pathways. The p53 signaling pathway was enriched in both METH administered and luteolin pretreated rats. Meanwhile, luteolin significantly suppressed METH-induced elevation of p53, caspase9, caspase3, cleaved caspase3, the ratio of Bax/Beclin-2, as well as autophagy-related Beclin-1, Atg5, and LC3-II. Luteolin also relieved METH-induced hepatotoxicity by decreasing inflammation factors, including TNF-α, IL-1β, and IL-18. Moreover, the levels of PI3K,

Indexed as

hepatotoxicityluteolinmethamphetaminep53 signaling pathwayprotective effect

Identifiers

PMID33679421
PMCPMC7933587
OpenAlexW3130942086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.